Chinese market for Medical rehabilitation equipment

We just highlight some strategic hints to enter Chinese market of Medical rehabilitation equipment. For further free evaluation fill contact form below. We would like meet you in a meeting with gap analysis.


Product code of Medical rehabilitation equipment in China


The product code is 6 digits in China (19-01-01). Determination of product code is essential of classification and others pathway of registration.


Here are all product codes of Medical rehabilitation equipment in China:


19-01 Rehabilitation equipment for cognitive speech and hearing disorders


01 Rehabilitation equipment for cognitive disorders 02 Visual rehabilitation equipment 03 Auditory rehabilitation equipment 04 Rehabilitation equipment for speech disorders 05 True ear tester 06 Speaker aid 07 Hearing aid


19-02 Sports rehabilitation training equipment


01 Gait training equipment 02 Rehabilitation training bed 03 Balance training equipment 04 Vibration training equipment 05 Joint training equipment 06 Pelvic floor muscle training equipment 07 Tongue muscle rehabilitation trainer


19-03 Walking aids


01 Medical wheelchair 02 Auxiliary walking and standing equipment


19-04 Orthopedic fixation equipment


01 Orthosis 02 Fixation device



Product specific guidance and standards (for payed clients)



Other registration elements


Type testing is one third of Chinese registration. Starting with product technical requirment (PTR), overcoming trouble shoooting at locla testing and ending with testing report.

There are risk based clinical approach in China:

CER based on exemption catalog

CER based on equivalent or similar devices

CER with accepted overseas clinical study

Clinical study in China

Description Title

Time and cost matter for market access. There are clear defined registration cost and review time in China.

Significant change is as a mythos in CHina because a change guidance is missing. Be smart with us to actively manage design change.

Post market surveillance is extensive in EU however straightforward in China